Vivani Medical's (VANI) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Vivani Medical (NASDAQ:VANI - Free Report) in a report released on Thursday morning,Benzinga reports. The firm currently has a $4.00 price target on the stock.

Vivani Medical Stock Performance

Shares of VANI stock traded up $0.01 during trading hours on Thursday, hitting $1.10. The company had a trading volume of 60,744 shares, compared to its average volume of 178,770. The firm has a market capitalization of $65.16 million, a price-to-earnings ratio of -2.44 and a beta of 3.20. Vivani Medical has a 12 month low of $1.03 and a 12 month high of $2.22. The firm's fifty day moving average is $1.16 and its 200 day moving average is $1.22.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Wealthedge Investment Advisors LLC acquired a new position in shares of Vivani Medical in the 4th quarter worth approximately $43,000. Jane Street Group LLC acquired a new position in shares of Vivani Medical in the 4th quarter worth approximately $66,000. Northern Trust Corp boosted its holdings in shares of Vivani Medical by 19.1% in the 4th quarter. Northern Trust Corp now owns 71,915 shares of the company's stock worth $83,000 after acquiring an additional 11,540 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Vivani Medical by 4.6% in the 3rd quarter. Geode Capital Management LLC now owns 342,891 shares of the company's stock worth $401,000 after acquiring an additional 15,008 shares in the last quarter. 6.78% of the stock is owned by institutional investors and hedge funds.

Remove Ads

About Vivani Medical

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.